144 filed Nov 4, 2026 at 16:00 ET
Dov Bergwerk, Teva's Senior VP, General Counsel and Corporate Secretary, filed a Form 144 notice to sell 26,260 ordinary shares with an approximate market value of $1.1 million. The sale is tied to a stock option exercise and sale transaction, executed on the filing date at an indicative price of $41.72 per share. Relative to Teva's $47.4B market cap, the sale is small and routine for an executive exercising options.